The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
Keli Lima(Universidade de São Paulo), João Agostinho Machado‐Neto(Universidade de São Paulo)
Cited by 1
Related Papers
Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
|Cell Death and Disease|2018|30
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
|Blood Cancer Journal|2022|29
Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
|Scientific Reports|2019|22
Targeting glioma cells by antineoplastic activity of reversine
|Oncology Letters|2021|13